A call asking you to bring your newborn back for testing can be frightening, especially when your baby looks well. The call does not necessarily mean a diagnosis has been made. It does mean that the screening team needs you to complete the next step.
Ask what the result was, where to go, and how soon your baby needs to be seen. Follow the team’s instructions promptly. Some screened conditions need care before obvious symptoms develop.
Three screens, three sets of results
In US newborn-screening programmes, screening includes a blood-spot test, hearing screening and pulse oximetry to look for certain serious heart conditions. They assess different things. A completed heel-prick sample does not tell you that hearing or heart screening was completed. HRSA describes the three components.
This guide draws on US public-health resources. The conditions included, timing, repeat-screen requirements and routes for follow-up vary between countries and programmes. Your local screening service is the authority on your baby’s schedule.
What the words on a blood-spot result mean
| Report wording | What it usually means | What to clarify |
|---|---|---|
| In range / negative | The screen did not suggest the conditions it assessed. | Are all screening components complete? |
| Out of range / positive | A finding needs further assessment. | Which follow-up test or specialist visit is needed, and when? |
| Borderline / inconclusive | The result needs further screening or testing. | Is a repeat sample or a different test required? |
| Unsatisfactory sample / repeat requested | A usable result may not have been obtained. | Why must the sample be repeated, and what is the deadline? |
An out-of-range result can turn out to be a false positive. A reassuring result can occasionally miss a condition. These possibilities are reasons to complete follow-up and respond to symptoms, not reasons to ignore screening. See HRSA’s result explanations.
Example 1: the baby looks well after an out-of-range result
Fictional teaching example. A screening team calls about a possible metabolic condition and asks a family to attend for further assessment that day. Their baby is feeding and seems comfortable. The parents wonder whether they can wait until the next routine visit.
Looking well does not resolve the screening question. Some conditions are sought precisely because early action can prevent serious problems. The family should follow the requested timing and tell the team immediately if transport or another barrier makes attendance difficult. NICHD explains why prompt follow-up matters.
Do not start a special diet, change formula or give a treatment based on an online description. The screening or clinical team should give condition-specific instructions, including any action needed while confirmation is pending.
Example 2: a second sample is requested
Fictional teaching example. A family hears, “We need another blood spot,” and assumes the first sample showed a disease. They call back and ask whether the request concerns sample quality, a programme’s scheduled second screen, or an abnormal finding. Those are different situations.
Some US programmes routinely use two screens; additional samples may also be needed for other reasons. Keep the appointment even if the request is only to obtain an adequate specimen. A test that never produced a usable result cannot provide reassurance. HRSA describes the screening process and local variation.
Write down the reason in the baby’s records. That small detail helps the next clinician distinguish an incomplete screen from a confirmed normal or abnormal result.
Example 3: blood-spot results are normal, but hearing follow-up is outstanding
Fictional teaching example. Parents receive reassuring blood-spot results and nearly cancel an audiology appointment. The appointment was arranged because their baby did not pass hearing screening. The blood result does not answer the hearing question.
A hearing-screen referral is not itself a diagnosis of permanent hearing loss. It still needs the recommended follow-up. NIDCD’s US guidance describes screening by one month, diagnostic assessment by three months when needed, and intervention by six months for identified hearing loss, with earlier action encouraged. Do not postpone an appointment already offered sooner. See NIDCD’s family guide.
Keep a simple record that closes the loop
The following is an original appointment worksheet, not a diagnostic tool. Keep it with the discharge information and bring it to follow-up visits.
| Screen | Date and result received | Next action and deadline | Person or service to contact |
|---|---|---|---|
| Blood spot | Write the exact wording | Record any repeat or diagnostic test | Name and telephone number |
| Hearing | Record each ear if reported | Record any audiology appointment | Name and telephone number |
| Pulse oximetry | Record the discharge result | Record any heart assessment | Name and telephone number |
Ask who will contact you if a result is delayed, and when you should call if you have heard nothing. Check that both the screening service and your baby’s clinician have your current telephone number. If you move, arrange transfer of outstanding results and appointments.
What screening cannot promise
Newborn screening is not a test for every genetic disease, and a normal result does not replace assessment of a baby who becomes unwell. Seek urgent medical assessment for serious symptoms such as breathing difficulty, marked difficulty waking or inability to feed, regardless of screening results. Do not wait for a screening callback in that situation.
Understanding a specific follow-up pathway
For background after a clinician has explained the suspected condition, our guides cover phenylketonuria, sickle cell disease and trait, and cystic fibrosis. Their inclusion here does not mean every programme screens for them in the same way.
For example, an out-of-range cystic-fibrosis screen needs the appropriate confirmatory pathway even if testing during pregnancy was reassuring. HRSA explains CF screening follow-up. Our genetics-care finder can support later planning; urgent screening follow-up should go through the team that contacted you.